BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30099251)

  • 1. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer.
    Echevarría I; Zafon E; Barrabés S; Martínez MÁ; Ramos-Gómez S; Ortega N; Manzano BR; Jalón FA; Quesada R; Espino G; Massaguer A
    J Inorg Biochem; 2022 Jun; 231():111790. PubMed ID: 35306449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
    Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel half-sandwich rhodium(III) and iridium(III) photosensitizers for dual chemo- and photodynamic therapy.
    Su W; Luo Z; Dong S; Chen X; Xiao JA; Peng B; Li P
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():448-454. PubMed ID: 31048016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
    Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
    J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles.
    Rylands LI; Welsh A; Maepa K; Stringer T; Taylor D; Chibale K; Smith GS
    Eur J Med Chem; 2019 Jan; 161():11-21. PubMed ID: 30342422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
    Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
    Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
    Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
    Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic octahedral molybdenum cluster complexes functionalized with mitochondria-targeting ligands: photodynamic anticancer and antibacterial activities.
    Kirakci K; Zelenka J; Rumlová M; Cvačka J; Ruml T; Lang K
    Biomater Sci; 2019 Mar; 7(4):1386-1392. PubMed ID: 30656318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Half-sandwich" Schiff-base Ir(III) complexes as anticancer agents.
    Mou ZD; Deng N; Zhang F; Zhang J; Cen J; Zhang X
    Eur J Med Chem; 2017 Sep; 138():72-82. PubMed ID: 28646657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK; Law WH; Liu HW; Lo KK
    Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.